Loading the session
Loading the session
Loading instrument
$4.10
+5.94%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:44 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +11.8% (SPY −1.6%). 3 months: −18.0% (SPY −0.4%). 1 year: −4.0% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: IVA, SPY · as of 4 Nov 2026
The 4 Nov 2026 close of $3.87 was 2.6% above its 50-day average ($3.77) and 20.2% below its 200-day average ($4.85). It has closed below the 200-day for 119 sessions, since 18 May 2026. The 50-day average crossed below the 200-day on 3 Jun 2026, 107 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Closed at $3.87 on 4 Nov 2026: 46.9% below the 52-week high of $7.29 (26 Jan 2026) and 37.2% above the low of $2.82 (14 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
8.2M shares were sold short at the 15 Oct 2026 settlement, 3.4% of the 238.0M shares outstanding; covering them would take 2.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.
October 14, 2024
+41.27%May 31, 2023
+30.20%October 7, 2022
+72.79%